Author

Jafar Rezaei

Delft University of TechnologyORCID 0000-0002-7407-9255Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Kateřina StaňkováiD· 3 shared Mohammadreza SatouriiD· 2 shared Anne‐Marie C. DingemansiD· 1 shared Arina SobolevaiD· 1 shared Eva MolnárováiD· 1 shared I GrossmanniD· 1 shared Joel S. BrowniD· 1 shared Kailas Shankar HonasogeiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Kateřina StaňkováORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Assessing the Operational Feasibility of Evolutionary Therapy in Metastatic Non-Small Cell Lung Cancer

Arina Soboleva, Kailas Shankar Honasoge, Eva Molnárová, Ties A. Mulders, Anne‐Marie C. Dingemans, I Grossmann, Jafar Rezaei, Kateřina Staňková

This study evaluates the clinical feasibility of evolutionary therapy for NSCLC by simulating its performance under real-world constraints like measurement error and appointment delays.

Journal of Evolutionary Biology · Oct 30, 2026Peer-reviewedCancer Biology

Persister cells and their effects on cancer stabilization therapy

Mohammadreza Satouri, Philipp M. Altrock, Jafar Rezaei, Kateřina Staňková

This study develops an evolutionary game theory model to analyze how persister cells influence cancer dynamics under treatment, showing they can stabilize or destabilize tumors based on transition rates and competition.

bioRxiv · Oct 16, 2026 · PreprintCancer Biology

Initial tumor composition shapes resistance evolution and treatment outcomes in non-small cell lung cancer

Mohammadreza Satouri, Joel S. Brown, Jafar Rezaei, Kateřina Staňková, Rachel Cavill

This study shows that initial tumor composition influences resistance evolution and treatment outcomes in NSCLC, with resistance fitness effects varying based on initial resistant cell proportion.

bioRxiv · Sep 1, 2026 · PreprintCancer Biology